2767-9764

Cancer Research Communications

American Association for Cancer Research

View prefix report (10.1158)

Health Score

0 Excellent

Metadata coverage

Abstract
ORCID
References
License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder
Award / grant

Affiliation & institutional identifiers

Affiliation
ROR ID

Update policy

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

1

Add abstracts to 19 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Low impact19 DOIs
2

Deposit reference lists for 19 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact19 DOIs
3

Attach ORCID iDs across 19 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Low impact19 DOIs

DOIs for this ISSN

Showing the top 5 of 965 DOIs, ordered by correction priority.

# Title Missing Priority Citations
1 Correction: Comprehensive Immunoprofiling of High-risk Oral… (10.1158/2767-9764.crc-22-0193)
Abstract ORCID
30.10 3
2 Correction: A Ketogenic Diet in Combination with Gemcitabine… (10.1158/2767-9764.crc-22-0510)
Abstract ORCID
15.05 1
3 Correction: Maternal Embryonic Leucine Zipper Kinase Is Asso… (10.1158/2767-9764.crc-24-0046)
Abstract ORCID
15.05 1
4 IDENTIFICATION OF MUC1-C AS A TARGET FOR SUPPRESSING PROGRES… (10.1158/2767-9764.crc-24-0011)
References
7.53 1
5 Cancer-Related Fatigue and the Additive Effect of Treatment… (10.1158/2767-9764.crc-24-0048)
ORCID
7.53 1
6 Race-associated Molecular Changes in Gynecologic Malignancie… (10.1158/2767-9764.crc-21-0018)
0.00 8
7 MYCMI-7: A Small MYC-Binding Compound that Inhibits MYC: MAX… (10.1158/2767-9764.crc-21-0019)
0.00 21
8 Combinatorial Natural Killer Cell–based Immunotherapy Approa… (10.1158/2767-9764.crc-21-0020)
0.00 19
9 An Unbiased Functional Genetics Screen Identifies Rare Activ… (10.1158/2767-9764.crc-21-0021)
0.00 7
10 The Genetic Landscape of Ocular Adnexa MALT Lymphoma Reveals… (10.1158/2767-9764.crc-21-0022)
0.00 17
11 Sex- and Mutation-Specific p53 Gain-of-Function Activity in… (10.1158/2767-9764.crc-21-0026)
0.00 14
12 8-Azaadenosine and 8-Chloroadenosine are not Selective Inhib… (10.1158/2767-9764.crc-21-0027)
0.00 35
13 <i>In Silico</i> Epitope Prediction Anal… (10.1158/2767-9764.crc-21-0029)
0.00 4
14 Affordable Prices Without Threatening the Oncological R&amp;… (10.1158/2767-9764.crc-21-0031)
0.00 8
15 Association of PD-L1 Expression on Tumor and Immune Cells wi… (10.1158/2767-9764.crc-21-0032)
0.00 11
16 HSP70 Inhibition Blocks Adaptive Resistance and Synergizes w… (10.1158/2767-9764.crc-21-0033)
0.00 7
17 Rejuvenating Effector/Exhausted CAR T Cells to Stem Cell Mem… (10.1158/2767-9764.crc-21-0034)
0.00 23
18 Dipeptidyl Peptidase (DPP)-4 Inhibitor Impairs the Outcomes… (10.1158/2767-9764.crc-21-0042)
0.00 10
19 BRCA1-Associated RING Domain-1 (BARD1) Loss and GBP1 Express… (10.1158/2767-9764.crc-21-0047)
0.00 16
20 Comprehensive Immunoprofiling of High-Risk Oral Proliferativ… (10.1158/2767-9764.crc-21-0060)
0.00 25
21 BRCA1/ATF1-Mediated Transactivation is Involved in Resistanc… (10.1158/2767-9764.crc-21-0064)
0.00 12
22 The ADAM17-directed Inhibitory Antibody MEDI3622 Antagonizes… (10.1158/2767-9764.crc-21-0067)
0.00 7
23 Nuclear Receptor 4A2 (NR4A2/NURR1) Regulates Autophagy and C… (10.1158/2767-9764.crc-21-0073)
0.00 17
24 Intentional Modulation of Ibrutinib Pharmacokinetics through… (10.1158/2767-9764.crc-21-0076)
0.00 15
25 A Novel PHD2/VHL-mediated Regulation of YAP1 Contributes to… (10.1158/2767-9764.crc-21-0084)
0.00 11
26 Phase I Study of High-Dose <scp>l</scp>-Methylfolate in Comb… (10.1158/2767-9764.crc-21-0088)
0.00 1
27 Inhibiting ERK5 Overcomes Breast Cancer Resistance to Anti-H… (10.1158/2767-9764.crc-21-0089)
0.00 9
28 Brain Neural Progenitors are New Predictive Biomarkers for B… (10.1158/2767-9764.crc-21-0090)
0.00 2
29 The Wnt Pathway Inhibitor RXC004 Blocks Tumor Growth and Rev… (10.1158/2767-9764.crc-21-0095)
0.00 34
30 Influence of Germline<i>BRCA</i>Genotype on the Survival of… (10.1158/2767-9764.crc-21-0099)
0.00 4
31 Proteome Analysis of Pancreatic Tumors Implicates Extracellu… (10.1158/2767-9764.crc-21-0100)
0.00 10
32 MYC Inhibition Halts Metastatic Breast Cancer Progression by… (10.1158/2767-9764.crc-21-0103)
0.00 25
33 Combined Treatment with a WNT Inhibitor and the NSAID Sulind… (10.1158/2767-9764.crc-21-0105)
0.00 13
34 Tumor Suppressor PLK2 May Serve as a Biomarker in Triple-Neg… (10.1158/2767-9764.crc-21-0106)
0.00 17
35 World Trade Center Dust Exposure Promotes Cancer in PTEN-def… (10.1158/2767-9764.crc-21-0111)
0.00 1
36 A Randomized Clinical Trial of Precision Prevention Material… (10.1158/2767-9764.crc-21-0114)
0.00 15
37 Targeting the Ezrin Adaptor Protein Sensitizes Metastatic Br… (10.1158/2767-9764.crc-21-0117)
0.00 11
38 A Genome-Wide Gene-Based Gene–Environment Interaction Study… (10.1158/2767-9764.crc-21-0119)
0.00 10
39 Three-dimensional Imaging Reveals Immune-driven Tumor-associ… (10.1158/2767-9764.crc-21-0123)
0.00 5
40 Tumor Purity in Preclinical Mouse Tumor Models (10.1158/2767-9764.crc-21-0126)
0.00 16
41 Remodeling of the Tumor Microenvironment Through PAK4 Inhibi… (10.1158/2767-9764.crc-21-0133)
0.00 12
42 Impaired Antitumor Immune Response in <i… (10.1158/2767-9764.crc-21-0134)
0.00 16
43 Tumor Cell Extrinsic Synaptogyrin 3 Expression as a Diagnost… (10.1158/2767-9764.crc-21-0135)
0.00 2
44 Pharmacologic Inhibition of SHP2 Blocks Both PI3K and MEK Si… (10.1158/2767-9764.crc-21-0137)
0.00 9
45 Potent Stimulation of the Androgen Receptor Instigates a Vir… (10.1158/2767-9764.crc-21-0139)
0.00 18
46 Methylated Septin9 (m<i>SEPT9</i>): A Promising Blood-Based… (10.1158/2767-9764.crc-21-0142)
0.00 45
47 Persistent Ethnicity-Associated Disparity in Antitumor Effec… (10.1158/2767-9764.crc-21-0143)
0.00 26
48 Resolving the Heterogeneous Tumor-Centric Cellular Neighborh… (10.1158/2767-9764.crc-21-0146)
0.00 9
49 NetrinG1+ Cancer-Associated Fibroblasts Generate Unique Extr… (10.1158/2767-9764.crc-21-0147)
0.00 34
50 Type-I Interferon Signaling Is Essential for Robust Metronom… (10.1158/2767-9764.crc-21-0148)
0.00 7